Prolonged GIP receptor activation using stable mini-PEGylated GIP improves glucose homeostasis and beta-cell function in age-related glucose intolerance

Peptides

Volumn 30, Issue 2, 2009, Pages 219-225

  Kerr, Barry D ^a   Irwin, Nigel ^a   Flatt, Peter R ^a   Gault, Victor A ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Aging; GIP; GIP mPEG ; Glucose tolerance; Insulin secretion

Indexed keywords

ADIPONECTIN; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; INSULIN; PEGYLATED GASTRIC INHIBITORY POLYPEPTIDE; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG HALF LIFE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HORMONAL REGULATION; INSULIN RELEASE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; EATING; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE INTOLERANCE; INCRETINS; INSULIN-SECRETING CELLS; MALE; MICE; POLYETHYLENE GLYCOLS; RECEPTORS, GASTROINTESTINAL HORMONE; RESISTIN; TRIGLYCERIDES;

MUS;

EID: 58149483520     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.10.017     Document Type: Article

References (29)

1. Baggio L.L., and Drucker D.J. Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu Rev Med 57 (2006) 265-281
2. Bailey C.J., and Flatt P.R. Hormonal control of glucose homeostasis during development and aging in mice. Metabolism 31 (1982) 238-246
3. Bailon P., and Berthold W. Polyethylene glycol-conjugated pharmaceutical proteins. Pharm Sci Technol Today 1 (1998) 352-356
4. Chang A.M., and Halter J.B. Aging and insulin secretion. Am J Physiol Endocrinol Metab 284 (2003) E7-E12
5. Creutzfeldt W. The entero-insular axis in type 2 diabetes-incretins as therapeutic agents. Exp Clin Endocrinol Diabetes 109 (2001) S288-S303
6. de Vegt F., Dekker J.M., Jager A., Hienkens E., Kostense P.J., Stehouwer C.D., et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 285 (2001) 2109-2113
7. Ehses J.A., Pelech S.L., Pederson K.A., and McIntosh C.H. Glucose-dependent insulinotropic polypeptide activates Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway. J Biol Chem 277 (2002) 37088-37097
8. Elahi D., Muller D.C., Andersen D.K., Tobin J.D., and Andres R. The effect of age and glucose concentration on insulin secretion by the isolated perfused pancreas. Endocrinology 116 (1985) 11-16
9. Flatt P.R., and Bailey C.J. Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 20 (1981) 573-577
10. Gault V.A., Kerr B.D., Irwin N., and Flatt P.R. C-terminal mini-PEGylation of glucose-dependent insulinotropic polypeptide exhibits metabolic stability and improved glucose homeostasis in dietary-induced diabetes. Biochem Pharmacol 75 (2008) 2325-2333
11. Hansotia T., Maida A., Flock G., Yamada Y., Tsukiyama K., Seino Y., and Drucker D.J. Extrapancreatic incretin receptors modulate glucose homeostasis, bodyweight, and energy expenditure. J Clin Invest 117 (2007) 143-152
12. Harris J.M., and Chess R.B. Effects of PEGylation on pharmaceuticals. Nat Rev Drug Discov 2 (2003) 214-224
13. Irwin N., Clarke G.C., Green B.D., Greer B., Harriott P., Gault V.A., et al. Evaluation of the antidiabetic activity of DPP-IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide. Biochem Pharmacol 72 (2006) 719-728
14. Irwin N., Flatt P.R., and Gault V.A. GIP-based therapeutics for diabetes and obesity. Curr Chem Biol 2 (2008) 61-68
15. Irwin N., Green B.D., Gault V.A., Harriot P., O'Harte F.P., and Flatt P.R. Stable agonist of glucose-dependent insulinotropic polypeptide (GIP) restores pancreatic beta cell responsiveness but not glucose intolerance in aging mice. Exp Gerontol 41 (2006) 151-156
16. Irwin N., McClean P.L., Harriott P., and Flatt P.R. Beneficial effects of sub-chronic activation of glucagon-like peptide-1 (GLP-1) receptors on deterioration of glucose homeostasis and insulin secretion in aging mice. Exp Gerontol 42 (2007) 296-300
17. Kieffer T.J., McIntosh C.H., and Pederson R.A. Degradation of glucose-dependant insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136 (1995) 3585-3596
18. Meier J.J., Nauck M.A., Kranz D., Holst J.J., Deacon C.F., Gaeckler D., et al. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. Diabetes 53 (2004) 654-662
19. Nyberg J., Jakobsson C., Anderson M.F., and Eriksson P.S. Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain. J Neurosci Res 85 (2007) 2099-2119
20. Resnick H.E., Harris M.I., Brock D.B., and Harris T.B. American diabetes association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the third national health and nutrition examination survey. Diabetes Care 23 (2000) 176-180
21. Salehi M., Aulinger B.A., and D'Alessio D.A. Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins. Endocrine Rev 29 (2008) 367-379
22. Scheen A.J. Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion?. Diabetes Metab 2 (2005) 5S27-5S34
23. Stevens J.F. Determination of glucose by an automated analyser. Clin Chem Acta 32 (1971) 199-201
24. Szoke E., Shrayyef M.Z., Messing S., Woerle H.J., van Haeften T.W., Meyer C., et al. Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care 31 (2008) 539-543
25. Trumper A., Trumper K., Truisheim H., Arnold R., Goke B., and Horsch D. Glucose-dependant insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signalling. Mol Endocrinol 15 (2001) 1559-1570
26. Yip R.G., Boylan M.O., Kieffer T.J., and Wolfe M.M. Functional GIP receptors are present on adipocytes. Endocrinology 139 (1998) 4004-4007
27. Yoshida K., Burton G.F., McKinney J.S., Young H., and Ellis E.F. Brain and tissue distribution of polyethylene glycol-conjugated superoxide dismutase in rats. Stroke 23 (1992) 865-869
28. Zhong Q., Itokawa T., Sridhar S., Ding K.H., Xie D., Kang B., et al. Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am J Physiol Endocrinol Metab 292 (2007) E543-E548
29. 37PAL): novel long-acting analogues of glucose-dependent insulinotropic polypeptide with improved antidiabetic potential. J Med Chem 49 (2006) 1047-1054